Vident Advisory’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.09M Sell
22,506
-2,489
-10% -$784K 0.05% 298
2026
Q1
$8.21M Buy
24,995
+859
+4% +$308K 0.07% 241
2025
Q4
$8.48M Buy
24,136
+453
+2% +$165K 0.08% 220
2025
Q3
$8.75M Buy
23,683
+4,659
+24% +$1.8M 0.08% 217
2025
Q2
$7.53M Buy
19,024
+5,355
+39% +$2M 0.08% 200
2025
Q1
$5.09M Sell
13,669
-5,204
-28% -$1.98M 0.07% 232
2024
Q4
$6.8M Buy
18,873
+2,001
+12% +$741K 0.12% 169
2024
Q3
$6.1M Buy
16,872
+12,063
+251% +$4.16M 0.15% 129
2024
Q2
$1.64M Buy
+4,809
New +$1.63M 0.05% 438
2024
Q1
– Sell
-5,472
Closed -$1.64M – 1412
2023
Q4
$1.64M Buy
5,472
+255
+5% +$71.6K 0.04% 426
2023
Q3
$1.43M Buy
+5,217
New +$1.5M 0.04% 407

Other funds holding SYK

Vident Advisory's SYK Position: Q2 2026 in Review

Vident Advisory reduced its Stryker (SYK) stake by 10% in Q2 2026, selling an estimated $784K and leaving 22,506 shares worth $7.09M. The position accounts for 0.05% of the portfolio, ranked #298.

Vident Advisory first reported a position in SYK in Q3 2023 and has held it in 11 quarters since. The position peaked at $8.75M in Q3 2025. 2,267 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Vident Advisory held 22,506 shares of Stryker worth $7.09M as of Q2 2026.
  • Vident Advisory sold 2,489 Stryker shares in Q2 2026, an estimated $784K.
  • Stryker made up 0.05% of Vident Advisory's portfolio in Q2 2026, its #298 holding.
  • Vident Advisory first reported a position in Stryker in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Stryker position peaked at $8.75M in Q3 2025.
  • 2,267 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.